Sarepta Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Sarepta Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Sarepta Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 1, 2024 was 95.5M shares, a 2.11% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 95.5M +1.97M +2.11% Nov 1, 2024 10-Q 2024-11-06
Q2 2024 95.4M +2.09M +2.24% Aug 2, 2024 10-Q 2024-08-07
Q1 2024 94.5M +1.38M +1.48% Apr 26, 2024 10-Q 2024-05-01
Q3 2023 93.5M +5.76M +6.57% Oct 27, 2023 10-Q 2023-11-01
Q2 2023 93.3M +5.71M +6.52% Jul 28, 2023 10-Q 2023-08-02
Q1 2023 93.1M +5.65M +6.45% Apr 27, 2023 10-Q 2023-05-02
Q3 2022 87.8M +706K +0.81% Oct 28, 2022 10-Q 2022-11-02
Q2 2022 87.6M +7.72M +9.67% Jul 29, 2022 10-Q 2022-08-02
Q1 2022 87.5M +7.73M +9.69% Apr 29, 2022 10-Q 2022-05-04
Q3 2021 87.1M +8.16M +10.3% Oct 29, 2021 10-Q 2021-11-03
Q2 2021 79.8M +1.34M +1.71% Jul 30, 2021 10-Q 2021-08-04
Q1 2021 79.8M +1.79M +2.29% Apr 30, 2021 10-Q 2021-05-05
Q3 2020 78.9M +4.37M +5.86% Oct 30, 2020 10-Q 2020-11-05
Q2 2020 78.5M +4.16M +5.6% Jul 31, 2020 10-Q 2020-08-05
Q1 2020 78M +3.83M +5.17% May 1, 2020 10-Q 2020-05-06
Q3 2019 74.5M +7.72M +11.6% Nov 4, 2019 10-Q 2019-11-07
Q2 2019 74.3M +7.9M +11.9% Aug 2, 2019 10-Q 2019-08-07
Q1 2019 74.2M +8.62M +13.2% May 3, 2019 10-Q 2019-05-08
Q3 2018 66.8M +2.19M +3.39% Oct 26, 2018 10-Q 2018-10-31
Q2 2018 66.4M +2.11M +3.28% Aug 3, 2018 10-Q 2018-08-08
Q1 2018 65.5M +10.6M +19.2% Apr 30, 2018 10-Q 2018-05-03
Q3 2017 64.6M +10M +18.4% Oct 26, 2017 10-Q 2017-11-01
Q2 2017 64.3M +16.4M +34.3% Jul 28, 2017 10-Q 2017-08-03
Q1 2017 55M +9.18M +20.1% Apr 28, 2017 10-Q 2017-05-04
Q3 2016 54.6M +9.32M +20.6% Nov 3, 2016 10-Q 2016-11-07
Q2 2016 47.9M +6.39M +15.4% Aug 3, 2016 10-Q 2016-08-09
Q1 2016 45.8M +4.31M +10.4% Apr 29, 2016 10-Q 2016-05-05
Q3 2015 45.3M +3.96M +9.59% Oct 30, 2015 10-Q 2015-11-05
Q2 2015 41.5M +590K +1.44% Jul 31, 2015 10-Q 2015-08-06
Q1 2015 41.5M +788K +1.94% Apr 30, 2015 10-Q 2015-05-07
Q3 2014 41.3M +3.73M +9.92% Oct 31, 2014 10-Q 2014-11-06
Q2 2014 40.9M +7.4M +22.1% Jul 31, 2014 10-Q 2014-08-07
Q1 2014 40.7M +8.77M +27.5% Apr 30, 2014 10-Q 2014-05-08
Q3 2013 37.6M +12.1M +47.7% Oct 31, 2013 10-Q 2013-11-12
Q2 2013 33.5M +10.9M +48.2% Jul 31, 2013 10-Q 2013-08-08
Q1 2013 31.9M -104M -76.5% Apr 30, 2013 10-Q 2013-05-09
Q3 2012 25.5M -110M -81.2% Oct 31, 2012 10-Q 2012-11-07
Q2 2012 22.6M -113M -83.3% Jul 31, 2012 10-Q 2012-08-07
Q1 2012 136M May 1, 2012 10-Q 2012-05-10
Q3 2011 136M Oct 26, 2011 10-Q 2011-11-08
Q2 2011 136M Jul 27, 2011 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.